Yet another study, just published in the Journal of Urology, has indicated a clear association between the use of metformin along with androgen deprivation therapy (ADT) in the treatment of advanced forms of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, advanced, androgen, deprivation, metformin | 6 Comments »
To quote Howard himself, “Not much on PC, but FYI.” But on the other hand, it is very much about the sometimes challenging aspects of “being a patient” — prostate cancer included. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: diabetes, journey, metformin, patient, Wolinksy | 5 Comments »
There have been suggestions for some time (but no confirmation yet from large scale clinical trials) that treatment with the antidiabetic agent metformin may be beneficial in the management of at least some forms of prostate cancer. However, … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: antidiabetic, diabetes, metformin | 1 Comment »
According to an new article in the Journal of Biological Chemistry, the combination of metformin with a polo-like kinase 1 (Plk1) inhibitor known currently as BI2536 appears to be able to suppress the spread of prostate cancer that resists all other available treatments. … READ MORE …
Filed under: Drugs in development | Tagged: BI2536, castration-resistant, mCRPC, metformin | Leave a comment »
A newly published, retrospective, epidemiological study has looked at the potential role of metformin the the management of prostate cancer in > 350 men already diagnosed and being treated for diabetes in the Shared Equal Access Regional Cancer Hospital (SEARCH) database. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Uncategorized | Tagged: metformin, progressive, recurrent | 1 Comment »
A retrospective analysis of data from > 3,800 Canadian men has suggested that diabetic men who also had prostate cancer and were being treated with a commonly used, generic drug called metformin have a reduced risk for death from prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: diabetes, metformin, survival | 1 Comment »
A paper presented on Saturday at the annual meeting of the American Association for Cancer Research in Chicago has suggested the possibility of better outcomes after radical prostatectomy among men taking the diabetes drug metformin before their surgery … but the data are from a very small study. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: metformin, neoadjuvant. localized, radical prostatectomy, surgery | Leave a comment »
A newly published article in BJU International offers data from a small, randomized, pilot study of the use of metformin and lifestyle changes in the prevention of cardiovascular morbidity and androgen deprivation therapy (ADT)-related metabolic syndrome. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation, exercise, metformin, outcome | Leave a comment »
Each year the Prostate Cancer Foundation gives out its “Creativity Awards” — intended to support research into new ideas with the potential to significantly affect the diagnosis and treatment of prostate cancer. … READ MORE …
Filed under: Drugs in development | Tagged: anti-OX40, awards, Botox, creativity, metformin, research, TKI258 | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 